Search company, investor...
Science 37 company logo

Science 37

Founded Year



Acq - Pending | Acquired

Total Raised




About Science 37

Science 37 orchestrates digital clinical trials. Researchers can use the platform for end-to-end trial management and as a window into a study’s progression—it provides centralized data management with actionable insights available in real time. The platform integrates workflow and processes for physician investigators, mobile nurses, and coordinators across the patient journey, and also digitally automates and streamlines all aspects of data collection.

Headquarters Location

12121 Bluff Creek Drive Suite 100

Los Angeles, California, 90094,

United States


ESPs containing Science 37

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Biopharma Tech

These companies offer software that enables clinical research to be conducted across a far greater number of locations. This approach focuses on increasing the proportion of trial activities done remotely or at the patient’s home, as opposed to the traditional approach of bringing patients to a trial site.

Science 37 named as Leader among 7 other companies, including Medable, ObvioHealth, and Curebase.

Compete with Science 37?

Ensure that your company and products are accurately represented on our platform.

Science 37's Products & Differentiators

    Operating System (OS)

    The Science 37 Operating System (OS) enables universal access to patients and providers, leading to faster enrollment, greater retention and a more representative patient population.

Expert Collections containing Science 37

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Science 37 is included in 8 Expert Collections, including Clinical Trials Tech.


Clinical Trials Tech

364 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Conference Exhibitors

5,302 items


Digital Health 150

150 items

The winners of the second annual CB Insights Digital Health 150.


Digital Hospital

98 items

Startups recreating how healthcare is delivered


Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,854 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Latest Science 37 News

Author: Darcy Forman, Chief Delivery Officer, Science 37 In clinical trials,…

Nov 23, 2022

11/23/2022 | 10:06am EST Message : Author: Darcy Forman, Chief Delivery Officer, Science 37 In clinical trials, participant satisfaction is critical to achieve the best outcomes in patient care and research goals. A new, groundbreaking research study conducted by Life Science Strategy Group reveals the perceptions and preferences of trial participants as well as the general public, and how those determinants impact all factors of the trial lifecycle. These in-depth, granular results based on surveys with 360 clinical trial participants and 440 non-participants in both the United States and in Europe provides the most detailed and clearest look yet at what clinical trial factors are the most highly valued by patients - and which can inadvertently threaten a trial's success by inhibiting recruitment, retention or longitudinal goals. Trial administrators and managers can see in empirical terms how a robust investment in flexible clinical trial infrastructure improves patient satisfaction and trial outcomes. "Our research has identified those decentralized clinical trial elements that patients and non-participants value even more than direct interaction with a physician, and lead to greater satisfaction and willingness to participate in the future," said Jon Meyer, Principal, Life Science Strategy Group. The following takeaways from this landmark study crystallize the importance of agility and decentralization. The "hassle factor" is a huge barrier to clinical trial enrollment The likelihood - or even the perception - of inconvenience or an inflexible protocol is enough to deter patients. Trial administrators that struggle to recruit risk losing considerable time and money if they need to submit protocol amendments or initiate rescue study interventions. These survey results are unique in that they quantify - across trial types, demographics and therapeutic areas - just how strong people's aversion to inflexible clinical trial formats really is. Consider this: Among survey respondents who have NOT participated in a clinical trial, roughly one in three said they were turned off by the prospect of inconvenience or travel difficulties. Collectively, "hassle factor" was a greater deterrent than concern about trial safety, which was cited by 28% as a reason for nonparticipation, or even not having a need to participate, which was cited by 26%. By adhering to rigidly structured, site-based trial formats, trial administrators are turning off a plurality of potential subjects - a huge pool of people that otherwise might readily participate in a clinical trial. An agile trial framework that allows for a variety of in-person, at-home and remote touch points will be able to streamline enrollment. The survey found that 56% of people who have participated in a clinical trial within the past two years did so because they found the requirements convenient or imposed little to no travel burden. Travel can be a deterrent when not well-targeted A trial format that is launched on a platform equipped to incorporate hybrid or remote elements facilitates more strategic use of travel. By replacing some in-person visits to a lab site or physician's office with telehealth or mobile nursing care, trial coordinators can offer greater flexibility and autonomy to participants. The survey revealed that reduction - although not elimination - of travel should be a key goal. Among patients who reported having to travel at least a few times a week as a requirement of their clinical trial participation, 50% had a positive view of their in-person doctor visits. Half of the participants who traveled frequently for their trial also said that seeing their doctor in person left a favorable impression regarding their willingness to participate in future trials. These findings imply that trial administrators can improve compliance and foster greater satisfaction by being strategic about the necessary use of in-office or in-lab visits that require participants to travel. Making a clinical trial easier for patients to accommodate increases the chances that they will stick with it for the full length of the study. This, in turn, improves both their own health outcomes as well as the data quality collected by the administering staff. Unfamiliar technology lowers satisfaction and participation intent Traditional site-based clinical research doesn't leverage available technologies that could give patients more autonomy and greater choice around how, when and where they access care. Tech tools play a key role in the quest to improve the clinical trial experience, but too many manufacturers and CROs fail to use the right ones. By and large, the technology that makes the most impactful difference for patients in their day-to-day lives is that which is familiar to them. This study points to a high degree of comfort with and satisfaction with remote tools and comfort with familiar technology. The survey found that collecting health information via the patient's own smart mobile device was ranked as being easier than via a wearable device by a significant margin - 77% versus 64%. By contrast, a mere 8% characterized using their smartphone or tablet as "difficult," compared to 19% who said wearing a device was difficult. When patients use technological devices and features with which they are already familiar, they report overwhelmingly positive impacts on their satisfaction and successful completion of the trial. Accordingly, an interface that makes data capture hassle-free and lets patients receive care, ask questions and access medical advice using their own smartphones and tablets will elicit greater satisfaction and outcomes. Recruitment and retention suffer without in-home care options Manufacturers and CROs struggle to recruit enough patients because the traditional site-based model is perceived as inconvenient. When a trial administrator can offer flexible options such as in-home care, more people are willing to consider participating. Nearly two in three trial participants prefer future trials to have more remote technology that facilitates in-home care, and among those, 29% "strongly prefer" trials that incorporate features like the use of smartphones and tablets, online patient portals, telemedicine, and in-home contact with care providers. And among the general population - that is, survey respondents who had not participated in a clinical trial within the past two years - nearly two in three people expressed a preference for more in-home trial elements. Patient retention, willingness and ability to complete a trial is hindered by a lack of flexibility inherent in site-based models, especially for trials with a high frequency of travel. Travel itself is not the problem, but frequent travel is a deterrent to completion and willingness to participate in future trials. Incorporating decentralized elements can mitigate this by driving satisfaction with more flexible tools. Among trial participants who had to travel frequently, 100% reported positive associations with the use of online patient diaries, 80% characterized being able to email their doctor as "very positive" and 67% said the same about their interactions with in-home nursing providers. Learn more about how decentralized clinical trials and a flexible, nimble technological platform can make trial operations simpler and less expensive by offering options for how care is delivered and data is collected. See how enhancing data-capturing capability can improve patient outcomes and yield superior results by clicking here . Attachments

Science 37 Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Science 37 Rank

Science 37 Frequently Asked Questions (FAQ)

  • When was Science 37 founded?

    Science 37 was founded in 2014.

  • Where is Science 37's headquarters?

    Science 37's headquarters is located at 12121 Bluff Creek Drive, Los Angeles.

  • What is Science 37's latest funding round?

    Science 37's latest funding round is Acq - Pending.

  • How much did Science 37 raise?

    Science 37 raised a total of $106.5M.

  • Who are the investors of Science 37?

    Investors of Science 37 include LifeSci Acquisition II, dRx Capital, Lux Capital, Redmile Group, Google Ventures and 10 more.

  • Who are Science 37's competitors?

    Competitors of Science 37 include Medocity, Delve Health, Datacubed Health, Curebase, Reify Health, Alira Health, Eclincloud, Digital Artefacts, Medable, Saama Technologies and 15 more.

  • What products does Science 37 offer?

    Science 37's products include Operating System (OS) and 3 more.

Compare Science 37 to Competitors

Medable Logo

Medable is a decentralized clinical trial software company. The company's Software-as-a-Service (SaaS) cloud platform aims to provide a path to secure, HIPAA-compliant healthcare applications for researchers, startups, pharma, payers, and academia. This platform allows for supporting patient engagement clinical applications, storing personal health information, and complying with HIPAA and other regulations. Medable aims to enable patient-generated data to drive clinical research, healthcare delivery, and personalized and predictive medicine.

Curebase Logo

Curebase runs clinical trials via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. Curebase was founded in 2017 and is based in San Francisco, California.


THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.

Hawthorne Effect Logo
Hawthorne Effect

Hawthorne Effect uses a technology platform and trained freelance healthcare investigators (dubbed HEROs) to help improve clinical trial data quality by helping to prevent patient withdrawals and improve data collection and patient satisfaction rates.


ObvioHealth develops ClaimIt, a proprietary digital platform that utilizes a 100% online and mobile app interface to execute clinical trials. ClaimIt removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.

Delve Health Logo
Delve Health

Delve Health is a decentralized clinical trial platform that improves patient data collection by leveraging wearables, mobile phones, and connected devices. The company was founded in 2018 and is based in Minneapolis, Minnesota.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.